| 刘金旭 陈文梅.还原性谷胱甘肽治疗酒精性肝病临床观察[J].实用中西医结合临床,2006,(2):8-9 |
| 还原性谷胱甘肽治疗酒精性肝病临床观察 |
|
| |
| DOI： |
| 中文关键词: 还原性谷胱甘肽；酒精性肝病；VitE 益肝灵 |
| 英文关键词: Reducibility Glutathlone Alcoholic liver disease VitE Yi-gan-ling |
| 基金项目: |
|
| 摘要点击次数: 646 |
| 全文下载次数: 257 |
| 中文摘要: |
| 目的：观察还原性谷胱甘肽治疗酒精性肝病的疗效。方法：60例酒精性肝病患者随机分A组（治疗组）和B组（对照组），分别用还原性谷胱甘肽和门冬氨酸钾镁治疗，均口服维生素E及益肝灵。疗程均为15d。结果：治疗组总有效率93.3%，与对照组相比差异有显著性（P <0.005）；治疗组显效所需时间平均为(8.7±5.4)d，明显少于对照组（P <0.01）；治疗组ALT、AST、r-GT下降幅度均明显高于对照组（P <0.01）。结论：还原性谷胱甘肽治疗酒精性肝病疗效较好，优于门冬氨酸钾镁。 |
| 英文摘要: |
| Objective:To observe the efficacy of Glutathlone on the treatment of alcoholic liver diseases.Methods:60patients with alcoholic liver diseases were randomly divied into group A and group B.Patients in Group A received Glutathlone for fifteen days,Patients in Group B received potassium magnesium aspartcote for fifteen days.Results:In Group A,at the end of treatment, the total effective rate was 93.3%,which was significantly higher than that in Group B（P <0.005）.Time of marked effective was (8.7±5.4)d,which was significantly shorter than that in Group B（P <0.01）.The decrease of ALT and AST and r-GT after treatment were more significant in Group A than that in Group B（P <0.01）.Conclusion:Glutathlone has better efficacy than potassium magnesium aspartate on the treatment of patients with alcoholic liver disease.Patients with alcoholic liver diseases shoud be advised to receive Glutathlone. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|
